Ionis Pharmaceuticals logo

Ionis Pharmaceuticals share price today

(IONS)

Ionis Pharmaceuticals share price is $36.61 & ₹3,103.10 as on 14 Dec 2024, 2.30 'hrs' IST

$36.61

-0.4

(-1.08%)

Market is closed - opens 8 PM, 16 Dec 2024

View live Ionis Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Ionis Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Ionis Pharmaceuticals. Get details on the Indian mutual funds that are investing in Ionis Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Ionis Pharmaceuticals's financials.

Ionis Pharmaceuticals share price movements

  • $36.52
    $37.36

    Day's Volatility :2.25%

  • $33.33
    $54.44

    52 Weeks Volatility :38.78%

Ionis Pharmaceuticals Returns

PeriodIonis Pharmaceuticals, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-10.05%
-9.7%
0.0%
6 Months
-10.18%
-3.3%
0.0%
1 Year
-26.34%
4.2%
0.0%
3 Years
17.68%
4.2%
-18.1%

Ionis Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$37.01
Open
$37.2
Today's High
$37.36
Today's Low
$36.52
Market Capitalization
$6.0B
Today's Volume
$1.0M
52 Week High
$54.4446
52 Week Low
$33.33
Revenue TTM
$803.1M
EBITDA
$-336.3M
Earnings Per Share (EPS)
$-2.44
Profit Margin
-44.68%
Quarterly Earnings Growth YOY
-0.44%
Return On Equity TTM
-73.38%

How to invest in Ionis Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Ionis Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ionis Pharmaceuticals stock in both rupees (INR) and dollars (USD). Search for Ionis Pharmaceuticals or IONS on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ionis Pharmaceuticals or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ionis Pharmaceuticals shares which would translate to 0.023 fractional shares of Ionis Pharmaceuticals as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Ionis Pharmaceuticals

35%

Period: Sep 14, 2024 to Dec 13, 2024. Change in 30 Days versus previous period

Search volume for Ionis Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 14, 2024. 35% more investors are searching Ionis Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Ionis Pharmaceuticals

  • FMR Inc

    14.24%

  • Vanguard Group Inc

    9.54%

  • T. Rowe Price Investment Management,Inc.

    8.97%

  • BlackRock Inc

    6.54%

  • Wellington Management Company LLP

    5.53%

  • Bellevue Group AG

    4.99%

Analyst Recommendation on Ionis Pharmaceuticals

Buy

    66%Buy

    23%Hold

    10%Sell

Based on 30 Wall street analysts offering stock ratings for Ionis Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 30 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
20
19
19
Hold
7
8
7
Sell
3
3
3

Analyst Forecast on Ionis Pharmaceuticals

What analysts predicted

Upside of 67.16%

Current:

$36.61

Target:

$61.20

Insights on Ionis Pharmaceuticals

  • Price Movement

    In the last 3 months, IONS stock has moved down by -12.3%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 225.25M → 134.0M (in $), with an average decrease of 40.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -66.26M → -140.48M (in $), with an average decrease of 112.0% per quarter
  • IONS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 31.5% return, outperforming this stock by 57.2%
  • IONS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 32.1% return, outperforming this stock by 9.8%
  • Price to Sales

    ForIONS every $1 of sales, investors are willing to pay $6.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Ionis Pharmaceuticals Financials in INR & Dollars

FY18Y/Y Change
Revenue
$599.7M
↑ 18.12%
Net Income
$273.7M
↓ 4685.28%
Net Profit Margin
45.65%
↑ 46.83%
FY19Y/Y Change
Revenue
$1.1B
↑ 87.27%
Net Income
$294.0M
↑ 7.4%
Net Profit Margin
26.18%
↓ 19.47%
FY20Y/Y Change
Revenue
$729.0M
↓ 35.08%
Net Income
$-487.0M
↓ 265.65%
Net Profit Margin
-66.8%
↓ 92.98%
FY21Y/Y Change
Revenue
$810.0M
↑ 11.11%
Net Income
$-29.0M
↓ 94.05%
Net Profit Margin
-3.58%
↑ 63.22%
FY22Y/Y Change
Revenue
$587.0M
↓ 27.53%
Net Income
$-270.0M
↑ 831.03%
Net Profit Margin
-46.0%
↓ 42.42%
FY23Y/Y Change
Revenue
$787.6M
↑ 34.18%
Net Income
$-366.3M
↑ 35.66%
Net Profit Margin
-46.5%
↓ 0.5%
Q2 FY23Q/Q Change
Revenue
$188.0M
↑ 43.51%
Net Income
$-85.0M
↓ 31.45%
Net Profit Margin
-45.21%
↑ 49.45%
Q3 FY23Q/Q Change
Revenue
$144.0M
↓ 23.4%
Net Income
$-147.0M
↑ 72.94%
Net Profit Margin
-102.08%
↓ 56.87%
Q4 FY23Q/Q Change
Revenue
$324.5M
↑ 125.35%
Net Income
$-9.3M
↓ 93.7%
Net Profit Margin
-2.85%
↑ 99.23%
Q1 FY24Q/Q Change
Revenue
$119.5M
↓ 63.18%
Net Income
$-142.8M
↑ 1441.65%
Net Profit Margin
-119.5%
↓ 116.65%
Q2 FY24Q/Q Change
Revenue
$225.3M
↑ 88.5%
Net Income
$-66.3M
↓ 53.6%
Net Profit Margin
-29.42%
↑ 90.08%
Q3 FY24Q/Q Change
Revenue
$134.0M
↓ 40.51%
Net Income
$-140.5M
↑ 112.0%
Net Profit Margin
-104.84%
↓ 75.42%
FY18Y/Y Change
Profit
$597.9M
↑ 349.44%
FY19Y/Y Change
Profit
$1.1B
↑ 87.17%
FY20Y/Y Change
Profit
$717.0M
↓ 35.92%
FY21Y/Y Change
Profit
$799.0M
↑ 11.44%
FY22Y/Y Change
Profit
$573.0M
↓ 28.29%
FY23Y/Y Change
Profit
$778.5M
↑ 35.87%
Q2 FY23Q/Q Change
Profit
$185.0M
↑ 42.31%
Q3 FY23Q/Q Change
Profit
$142.0M
↓ 23.24%
Q4 FY23Q/Q Change
Profit
$321.4M
↑ 126.37%
Q1 FY24Q/Q Change
Profit
$111.7M
↓ 65.25%
Q2 FY24Q/Q Change
Profit
$215.5M
↑ 92.94%
Q3 FY24Q/Q Change
Profit
$132.9M
↓ 38.32%
FY18Y/Y Change
Operating Cash Flow
$602.9M
↑ 246.19%
Investing Cash Flow
$-929.6M
↑ 159.44%
Financing Cash Flow
$475.9M
↑ 107.72%
FY19Y/Y Change
Operating Cash Flow
$345.7M
↓ 42.66%
Investing Cash Flow
$-41.3M
↓ 95.56%
Financing Cash Flow
$100.0M
↓ 78.98%
FY20Y/Y Change
Operating Cash Flow
$35.9M
↓ 89.62%
Investing Cash Flow
$274.5M
↓ 765.01%
Financing Cash Flow
$-596.6M
↓ 696.48%
FY21Y/Y Change
Operating Cash Flow
$30.8M
↓ 14.19%
Investing Cash Flow
$194.9M
↓ 28.99%
Financing Cash Flow
$245.9M
↓ 141.22%
FY22Y/Y Change
Operating Cash Flow
$-274.4M
↓ 990.84%
Investing Cash Flow
$-262.6M
↓ 234.75%
Financing Cash Flow
$-55.3M
↓ 122.48%
Q2 FY23Q/Q Change
Operating Cash Flow
$-97.4M
↓ 27.34%
Investing Cash Flow
$69.5M
↓ 121.35%
Financing Cash Flow
$143.5M
↓ 70.83%

Ionis Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Ionis Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Ionis Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ionis Pharmaceuticals, Inc.
-1.67%
-10.18%
-26.34%
17.68%
-43.91%
Regeneron Pharmaceuticals, Inc.
-6.54%
-30.04%
-14.88%
11.15%
94.49%
Biontech Se
16.24%
36.11%
17.79%
-58.06%
243.94%
Alnylam Pharmaceuticals, Inc.
-4.84%
56.03%
32.5%
28.46%
104.33%
Vertex Pharmaceuticals Incorporated
-4.18%
-2.1%
12.92%
119.64%
111.27%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ionis Pharmaceuticals, Inc.
524.14
NA
25.7
-2.6
-0.73
-0.07
NA
4.2
Regeneron Pharmaceuticals, Inc.
19.12
19.12
1.15
45.03
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.23
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ionis Pharmaceuticals, Inc.
Buy
$6.0B
-43.91%
524.14
-44.68%
Regeneron Pharmaceuticals, Inc.
Buy
$84.9B
94.49%
19.12
33.61%
Biontech Se
Buy
$28.9B
243.94%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.8B
104.33%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$120.6B
111.27%
32.84
-4.51%

About Ionis Pharmaceuticals

ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. we are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. join us and experience our unique culture while you develop and expand your career. for more information about ionis and to apply for an open position, please visit our website: www.ionispharma.com.
Organization
Ionis Pharmaceuticals
Employees
927
CEO
Dr. Brett P. Monia Ph.D.
Industry
Health Technology

Management People of Ionis Pharmaceuticals

NameTitle
Dr. Brett P. Monia Ph.D.
Founder, CEO & Director
Ms. Elizabeth L. Hougen M.A., M.B.A., M.S.
Executive VP of Finance & CFO
Ms. B. Lynne Parshall Esq., J.D.
Director
Dr. Richard S. Geary Ph.D.
Executive VP & Chief Development Officer
Dr. Eric E. Swayze Ph.D.
Executive Vice President of Research
Mr. Darren Gonzales
Chief Accounting Officer & Senior VP
Dr. C. Frank Bennett BSc, Ph.D.
Executive VP & Chief Scientific Officer
Mr. D. Wade Walke Ph.D.
Senior Vice President of Investor Relations
Mr. Patrick R. O'Neil Esq.
Executive VP, Chief Legal Officer, General Counsel & Corporate Secretary
Ms. Hayley Soffer
Vice President of Corporate Communications

Important FAQs about investing in Ionis Pharmaceuticals from India :

What is Ionis Pharmaceuticals share price today?

Ionis Pharmaceuticals share price today stands at $36.61, Open: $37.20 ; Previous Close: $37.01 ; High: $37.36 ; Low: $36.52 ; 52 Week High: $54.44 ; 52 Week Low: $33.33. The stock opens at $37.20, after a previous close of $37.01. The stock reached a daily high of $37.36 and a low of $36.52, with a 52-week high of $54.44 and a 52-week low of $33.33.

Can Indians buy Ionis Pharmaceuticals shares?

Yes, Indians can invest in the Ionis Pharmaceuticals (IONS) from India.

With INDmoney, you can buy Ionis Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ionis Pharmaceuticals at zero transaction cost.

How can I buy Ionis Pharmaceuticals shares from India?

It is very easy to buy Ionis Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ionis Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Ionis Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Ionis Pharmaceuticals stocks?

To start investing in Ionis Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ionis Pharmaceuticals

Today’s highest price of Ionis Pharmaceuticals (IONS) is $37.36.

Today’s lowest price of Ionis Pharmaceuticals (IONS) is $36.52.

What is today's market capitalisation of Ionis Pharmaceuticals

Today's market capitalisation of Ionis Pharmaceuticals IONS is 6.0B

What is the 52 Week High and Low Range of Ionis Pharmaceuticals

  • 52 Week High

    $54.44

  • 52 Week Low

    $33.33

How much percentage Ionis Pharmaceuticals is down from its 52 Week High?

Ionis Pharmaceuticals (IONS) share price is $36.61. It is down by 32.76% from its 52 Week High price of $54.44.

How much percentage Ionis Pharmaceuticals is up from its 52 Week low?

Ionis Pharmaceuticals (IONS) share price is $36.61. It is up by 9.84% from its 52 Week Low price of $33.33.

What are the historical returns of Ionis Pharmaceuticals?

  • 1 Month Returns

    -1.67%

  • 3 Months Returns

    -10.18%

  • 1 Year Returns

    -26.34%

  • 5 Years Returns

    -43.91%

Who is the Chief Executive Officer (CEO) of Ionis Pharmaceuticals

Dr. Brett P. Monia Ph.D. is the current Chief Executive Officer (CEO) of Ionis Pharmaceuticals.